Gemelli Biotech to work on gastrointestinal diseases with new $19M funding
U.S.-headquartered Gemelli Biotech Corp, which focuses on precision diagnostics for gastrointestinal (GI) diseases, has completed…
23/06/2022 - 3 minutes
U.S.-headquartered Gemelli Biotech Corp, which focuses on precision diagnostics for gastrointestinal (GI) diseases, has completed…